1 June 2017 in The Application of Clinical Genetics
Congenital factor VII (FVII) deficiency is a rare inherited coagulopathy. The clinical manifestations and clinical findings vary widely, ranging from asymptomatic to life-threatening bleeding, including intracranial hemorrhage (ICH), with prolonged prothrombin time, normal partial thromboplastin time and normal platelet counts, which are confirmed by the low level of FVII assay. Treatment consists of fresh frozen plasma (FFP), prothrombin complex concentrates (PCCs), and recombinant activated FVII to treat bleeding and prophylactic therapy. Here, we report four patients with FVII levels T was the most common (50%) mutation identified in our study, followed by the K376X nonsense mutation (37.5%). In our study, we found that genetic information affected the severity of congenital FVII deficiency with ICH.
1 July 2021 in The Application of Clinical Genetics
VKVarissara Kaewchaivijit
+1
Background: Mercaptopurine is a key agent in childhood leukemia treatment. Genetic polymorphism in the genes involving thiopurine metabolisms is related to 6-MP related toxicity. Objective: This study aimed to determine the prevalence of ITPA:c.94C>A and NUDT15:c.415C>T polymorphisms among Thai children diagnosed with leukemia and their association with mercaptopurine-related myelotoxicity. Methods: Patients and survivors with a diagnosis of leukemia treated with mercaptopurine-containing chemotherapy regimens were enrolled. Clinical data and laboratory parameters during treatment as well as ITPA:c.94C>A and NUDT15:c.415C>T genotypes were analyzed. Results: In all, 99 patients with acute leukemia or survivors were enrolled in the study. The prevalences of ITPA:c.94C>A, NUDT15:c.415C>T, and co-occurrence of ITPA:c.94C>A and NUDT15:c.415C>T polymorphisms were 34, 17, and 4%, respectively. Numbers of absolute neutrophil count (ANC) and platelet count significantly decreased among patients carrying NUDT15:c.415C>T compared with NUDT15 wild type patients with p-values< 0.001 and 0.019, respectively. The differences were not observed among patients carrying ITPA:c.94C>A compared with ITPA wild type patients. According to multivariate GEE, NUDT15:c.415C>T and co-occurrence of ITPA:c.94C>A and NUDT15:c.415C>T had a significant negative effect on ANC during treatment (coefficient: − 463.81; CI: − 778.53, − 149.09; p-value=0.004 and coefficient: − 527.56; CI: − 1045.65, − 9.48; p-value=0.046). No significant effect of ITPA:c.94C>A on ANC during treatment was observed. Conclusion: ITPA:c.94C>A and NUDT15:c.415C>T polymorphisms are common among Thai children with leukemia. A strong association with mercaptopurine-related myelotoxicity was observed among patients carrying either NUDT15:c.415C>T alone or combined with ITPA:c.94C>A.
1 January 2025 in Case Reports in Pediatrics
PPPitchaya Pichantianchai
Pontocerebellar hypoplasia Type III (PCH3) is a rare, autosomal recessive neurodegenerative disorder linked to mutations in the PCLO gene, previously reported only in Omani populations. It presents with progressive microcephaly, intractable epilepsy, optic atrophy, and severe developmental delay. Here, we report the first documented case of PCH3 in an 8‐year‐old Thai girl with two novel PCLO truncation mutations. The patient presented with intractable epilepsy from 2 months of age and severe global developmental delay. Whole exome sequencing identified compound heterozygous mutations in the PCLO gene: c.9018_9037del (p.Tyr3007Ter) and c.8456del (p.Ala2819GlufsTer2), both of which were inherited from heterozygous parents. These mutations are predicted to result in a loss of Piccolo protein function. This case expands the mutational spectrum of PCLO ‐related PCH3 and highlights the importance of advanced molecular diagnostics in understanding and managing this rare neurodegenerative disorder. Given the lack of curative therapies, early genetic diagnosis is crucial in guiding patient care and genetic counseling.
1 January 2024 in Case Reports in Neurological Medicine
Rhabdomyolysis, an emergency medical condition linked to muscle necrosis and intracellular substances released into the bloodstream, significantly endangers military personnel in heat‐stress conditions. Rhabdomyolysis can also be an initial presentation in inherited muscle disorders. This study reports a novel case of calpainopathy (LGMDR1) diagnosed in a 19‐year‐old male military cadet who initially presented with recurrent rhabdomyolysis during training, a rare presentation in LGMD patients. Furthermore, a persistent creatine kinase (CK) elevation was observed at baseline. The diagnosis was confirmed by identifying a compound heterozygous of a novel frameshift, c.606dup (p.Ala203CysfsTer9), a mutation in exon 4, and a missense, c.956C > T (p.Pro319Leu), a mutation in exon 7 of the CAPN3 gene, via whole exome sequencing. This case highlights the necessity of diagnostic investigation in individuals who have persistent high CK levels during the rhabdomyolysis episodes and possibly CK screening prior to military training to preemptively identify and mitigate complications from undiagnosed muscular dystrophies in military personnel in the future.
3 March 2025 in Journal of Southeast Asian Medical Research
SLSethapong Lertsakulbunlue
Sethapong Lertsakulbunlue
Musculocontractural Ehlers-Danlos Syndrome (mcEDS) is a rare subtype of EDS, recognized as a multisystem congenital malformation characterized by multiple congenital contractures, distinctive craniofacial features, and characteristic skin manifestations. Most mcEDS is caused by biallelic loss-of-function mutations in the carbohydrate sulfotransferase 14 (CHST14) gene. This study reports a 15-year-old girl with classical clinical features of mcEDS who was first presented at Phramongkutklao Hospital in Thailand. The whole exome sequencing identified a homozygous frameshift, c.1033dup or p. Arg345ProfsTer10, mutation in exon 1 of the CHST14 gene. Sanger sequencing verified that this mutation was inherited from second-degree consanguineous parents. This study is the first to establish this frameshift mutation as a pathogenic mutation, thereby contributing to the literature on the CHST14 gene and enhancing our understanding of this rare condition. Our patient represents the first reported case of mcEDS in Thailand.